Rashtriya Newsflash

Posts From admin

Familial Chylomicronemia Syndrome Market Positioned for Significant Commercial Growth by 2036 – DelveInsight | Ionis Pharma, Novartis, Akcea Therapeutics, Arrowhead Pharma, Visirna Therapeutics

The Key Familial Chylomicronemia Syndrome Companies in the amrket include – Arrowhead Pharma, Visirna Therapeutics HK Limited, Ionis Pharmac, Novartis, Akcea Therapeutics, and others.   DelveInsight’s “Familial Chylomicronemia Syndrome Market

Read Full Article

Influenza A Infections Market Trends, Innovation, and Future Growth Outlook to 2036 – DelveInsight | Valenta Pharm JSC, Pneumagen, ModernaTX, Janssen R&D, Ainos, Genentech, TaiGen Biotechnology

The Key Influenza A Infections Companies in the market include – Roche and Shionogi, BioCryst Pharmaceuticals, Seqirus, Valenta Pharm JSC, Pneumagen, ModernaTX, Janssen Research & Development, LLC, Ainos, Inc., Genentech,

Read Full Article

PEComa Market Emerging as a High-Growth Healthcare Investment Space Through 2036 – DelveInsight | Aadi Bioscience, Sarcoma Oncology, Novartis

The Key PEComa Companies in the market include – Aadi Bioscience, Sarcoma Oncology, Novartis, and others.   DelveInsight’s report, “PEComa Market Insights, Epidemiology, and Market Forecast-2036” provides a comprehensive analysis

Read Full Article

Osteosarcoma Clinical Trial Pipeline Expands as 25+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Osteosarcoma Pipeline Insight, 2026” report provides comprehensive insights about 25+ companies and 32+ pipeline drugs in the Osteosarcoma pipeline landscape. It covers the Osteosarcoma pipeline drug profiles, including clinical

Read Full Article

Acne Vulgaris Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Acne Vulgaris Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Acne Vulgaris

Read Full Article

Polymyalgia Rheumatica Therapeutics Market Size in the 7MM is projected to grow at a significant CAGR by 2034, estimates DelveInsight

DelveInsight’s “Polymyalgia Rheumatica Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Polymyalgia Rheumatica,

Read Full Article

Non Muscle Invasive Bladder Cancer Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Non Muscle Invasive Bladder Cancer Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs

Read Full Article

Generalized Myasthenia Gravis Market Expected to Reach USD 15.6 Billion by 2036

DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on the Generalized Myasthenia Gravis (gMG) market

Read Full Article

Synovial Sarcoma Clinical Trial Pipeline Accelerates as 15+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Synovial Sarcoma Pipeline Insight, 2026” report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Synovial Sarcoma

Read Full Article

Autistic Disorder Clinical Trial Pipeline Gains Momentum: 25+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Autistic Disorder Pipeline Insight 2026” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in the Autistic

Read Full Article